Reprogramming Immunosuppressive Niches and the Cancer Immunity Cycle in Pancreatic Cancer with Neoantigen mRNA Plus Immune Adjuvant Nanocarrier Strategies

By afschroeder • November 23, 2025

Nel AE, Luo L, Liao YP, Wang X. Reprogramming Immunosuppressive Niches and the Cancer Immunity Cycle in Pancreatic Cancer with Neoantigen mRNA Plus Immune Adjuvant Nanocarrier Strategies. ACS Nano. 2025 Nov 22. doi: 10.1021/acsnano.5c14753. Epub ahead of print. PMID: 41273281.

Tags: General Internal Medicine, immune adjuvant nanocarrier, immune tolerance, immunotherapy, lipid nanoparticle, mRNA, Nano Medicine, Pancreatic ductal adenocarcinoma (PDAC), Post Doc, Publications, reprogramming, tumor microenvironment

Management Patterns and Outcomes for Relapsed or Refractory Hodgkin Lymphoma

Paniker AG, Marshalek JP, Chao E, Yashar D, Tomassetti S. Management Patterns and Outcomes for Relapsed or Refractory Hodgkin Lymphoma. J Hematol. 2026 Aug 31;15(4):188-197.[...]

Primary care physician characteristics and potentially inappropriate medications in older adults

Tatsuno Y, Sarkisian CA, Mafi JN, Kitajima K, Sato D, Tsugawa Y, Miyawaki A. Primary care physician characteristics and potentially inappropriate medications in older adults.[...]

When Prior Exposure Doesn’t Protect: Imported Plasmodium falciparum Malaria in a Returning Traveler With Waning Immunity

Nguyen M, Khan N, Patel N, Greeley A, Moriates C. When Prior Exposure Doesn't Protect: Imported Plasmodium falciparum Malaria in a Returning Traveler With Waning[...]